𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of terlipressin in hepatorenal syndrome

✍ Scribed by Inna Rozov-Ung; Mandip Panesar


Publisher
Wiley (John Wiley & Sons)
Year
2010
Tongue
English
Weight
95 KB
Volume
39
Category
Article
ISSN
0090-2934

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Terlipressin improves renal function in
✍ Aleksander Krag; SΓΈren MΓΈller; Jens H. Henriksen; Niels-Henrik Holstein-Rathlou; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

Patients with advanced cirrhosis and ascites are characterized by circulatory dysfunction with splanchnic vasodilatation and renal vasoconstriction, which often lead to ascites. The vasoconstrictor terlipressin improves renal function in hepatorenal syndrome (HRS). The aim of this study was to evalu

Predictors of response to therapy with t
✍ AndrΓ© Nazar; Gustavo Henrique Pereira; MΓ³nica Guevara; Marta MartΓ­n-Llahi; Marie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T

Tubular dysfunction in the deeply jaundi
✍ William G. Rector Jr; Gary C. Kanel; Jorge Rakela; Telfer B. Reynolds πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

We examined &-microglobulin (BZMG) excretion, an index of tubular function, in patients with hepatorenal syndrome, in whom tubular function is generally regarded as normal. Urine BBMG was significantly higher in these patients than in control patients with normal serum creatinine concentration. Pati

Hepatorenal syndrome: Is it truly the en
✍ Florence Wong πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

Background & Aims: Type 1 hepatorenal syndrome (HRS) is a severe complication of cirrhosis associated with a short median survival time (<2 weeks). Although the administration of terlipressin improves renal function, its effect on survival is unknown. This study investigated predictive factors of su